M&A Deal Summary

Igenomix Acquires Access Genomics

On December 17, 2020, Igenomix acquired life science company Access Genomics from Persistence Capital Partners

Acquisition Highlights
  • This is Igenomix’s 1st transaction in the Life Science sector.
  • This is Igenomix’s 1st transaction in Canada.
  • This is Igenomix’s 1st transaction in Ontario.

M&A Deal Summary
Date 2020-12-17
Target Access Genomics
Sector Life Science
Buyer(s) Igenomix
Sellers(s) Persistence Capital Partners
Deal Type Add-on Acquisition

Target

Access Genomics

Mississauga, Ontario, Canada
Access Genomics is a Canadian clinical genomics company that collaborates with researchers and scientific exemplars here in Canada, and around the world, in advanced and innovative genomics technologies. With expertise in genomics, molecular biology, embryology, and screening for diagnostics, Access Genomics is committed to working alongside IVF centers and medical fertility teams like yours. Access Genomics was formed in 2016 and is based in Mississauga, Ontario.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Igenomix

Valencia, Spain
Category Company
Founded 2011
Sector Life Science
DESCRIPTION

Igenomix engages in women’s health and reproductive genetic testing services for IVF clinics. The Company support c. 90,000 couples per year with a global footprint of 19 laboratories covering +80 countries. Igenomix was founded in 2011 and headquartered in Valencia, Spain.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Ontario) 1 of 1
Country (Canada) 1 of 1
Year (2020) 1 of 1

Seller(S) 1

SELLER

Persistence Capital Partners

Montreal, Quebec, Canada

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2008
Size Small
Type Sector Focused
DESCRIPTION

PCP Management Inc. (Persistence Capital Partners) is a specialist private equity group focused on investing in Canadian healthcare companies. The Firm targets to companies with post revenues, enterprise driven lead by strong management teams. Types of transaction includes MBOs, recapitalization, divestitures/carve outs and special situations. Persistence was formed in 2008 and is based in Montreal.

DEAL STATS #
Overall 7 of 8
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 3 of 4
State (Ontario) 2 of 3
Country (Canada) 7 of 8
Year (2020) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-04-14 Summit Veterinary

Aurora, Ontario, Canada

Summit Veterinary provides prescription drug services to veterinary clinics focused on companion animals. Summit Veterinary Pharmacy was founded in 1998 and is based in Aurora, Ontario.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-18 MDBriefCase Group

Toronto, Ontario, Canada

MDBriefCase Group, Inc. specializes in developing online, accredited and unaccredited continuing professional development for healthcare professionals. The company partners with prestigious regional and international medical associations to ensure its innovative education programs reflect the local experiences of healthcare professionals around the world. MDBriefCase Group was founded in 2001 and is based in Toronto, Canada.

Sell -
Mergr

Product

Company

Legal